SoftOx Solutions AS (OSL:SOFTX)
Norway
· Delayed Price · Currency is NOK 0.101
+0.003 (2.54%)
At close: Apr 28, 2026
SoftOx Solutions AS Revenue
In the year 2025, SoftOx Solutions AS had annual revenue of 15.58M NOK with 96.92% growth. SoftOx Solutions AS had revenue of 3.61M in the quarter ending December 31, 2025, with 123.16% growth.
Revenue
15.58M
Revenue Growth
+96.92%
P/S Ratio
16.17
Revenue / Employee
7.79M
Employees
2
Market Cap
252.04M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 15.58M | 7.67M | 96.92% |
| Dec 31, 2024 | 7.91M | 934.00K | 13.38% |
| Dec 31, 2023 | 6.98M | -133.61K | -1.88% |
| Dec 31, 2022 | 7.11M | -787.80K | -9.97% |
| Dec 31, 2021 | 7.90M | -1.94M | -19.69% |
| Dec 31, 2020 | Pro | Pro | Pro |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Oncoinvent ASA | 28.07M |
| Zelluna ASA | 53.00K |
| Arctic Bioscience AS | 45.90M |
| Aqua Bio Technology ASA | 101.51M |
| EXACT Therapeutics AS | 59.00K |
| Lytix Biopharma ASA | 377.00K |
| ArcticZymes Technologies ASA | 118.21M |
| Nykode Therapeutics AS | 4.57M |
SoftOx Solutions AS News
- 8 months ago - SoftOx Solutions AS Transcript: Investor Update - Transcripts
- 1 year ago - SoftOx Solutions AS Transcript: Investor Update - Transcripts
- 3 years ago - SoftOx Solutions AS Earnings Call Transcript: Q3 2022 - Transcripts
- 4 years ago - SoftOx Solutions AS Earnings Call Transcript: Q2 2022 - Transcripts